Clearmind Medicine Enters into Development Agreement to Advance Intranasal Formulation for its Proprietary Non-Hallucinogenic Neuroplastogen MEAI February 7, 2026 mental-health ONLY AVAILABLE IN PAID PLANS. Originally reported by benzinga. Read more Source: https://www.benzinga.com/pressreleases/26/02/g50442346/clearmind-medicine-enters-into-development-agreement-to-advance-intranasal-formulation-for-its-pro
